The DOI matches its Crossref record; 107 of the 107 references it cites were found in a registry or an index; none of the 18 sources its claims cite is checked for support yet.
COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates
Open accessPublished version of a preprint
Abstract
Utility of vaccine campaigns to control coronavirus 2019 disease (COVID-19) is not merely dependent on vaccine efficacy and safety. Vaccine acceptance among the general public and healthcare workers appears to have a decisive role in the successful control of the pandemic. The aim of this review was to provide an up-to-date assessment of COVID-19 vaccination acceptance rates worldwide. A systematic search of the peer-reviewed English survey literature indexed in PubMed was done on 25 December 2020. Results from 31 peer-reviewed published studies met the inclusion criteria and formed the basis for the final COVID-19 vaccine acceptance estimates. Survey studies on COVID-19 vaccine acceptance rates were found from 33 different countries. Among adults representing the general public, the highest COVID-19 vaccine acceptance rates were found in Ecuador (97.0%), Malaysia (94.3%), Indonesia (93.3%) and China (91.3%). However, the lowest COVID-19 vaccine acceptance rates were found in Kuwait (23.6%), Jordan (28.4%), Italy (53.7), Russia (54.9%), Poland (56.3%), US (56.9%), and France (58.9%). Only eight surveys among healthcare workers (doctors and nurses) were found, with vaccine acceptance rates ranging from 27.7% in the Democratic Republic of the Congo to 78.1% in Israel. In the majority of survey studies among the general public stratified per country (29/47, 62%), the acceptance of COVID-19 vaccination showed a level of ≥70%. Low rates of COVID-19 vaccine acceptance were reported in the Middle East, Russia, Africa and several European countries. This could represent a major problem in the global efforts to control the current COVID-19 pandemic. More studies are recommended to address the scope of COVID-19 vaccine hesitancy. Such studies are particularly needed in the Middle East and North Africa, Sub-Saharan Africa, Eastern Europe, Central Asia, Middle and South America. Addressing the scope of COVID-19 vaccine hesitancy in various countries is recommended as an initial step for building trust in COVID-19 vaccination efforts.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
This systematic review of 31 peer-reviewed survey studies from 33 countries found wide global variation in COVID-19 vaccine acceptance, with high rates in Ecuador, Malaysia, Indonesia, and China and low rates in Kuwait, Jordan, and several European countries. It concludes that vaccine hesitancy could be a major hindrance to pandemic control and recommends more studies in under-covered regions.
Key findings
- Among the general public, the highest COVID-19 vaccine acceptance rates were in Ecuador (97.0%), Malaysia (94.3%), Indonesia (93.3%), and China (91.3%); the lowest were in Kuwait (23.6%), Jordan (28.4%), Italy (53.7%), Russia (54.9%), Poland (56.3%), the US (56.9%), and France (58.9%).
- Among eight healthcare-worker surveys, acceptance ranged from 27.7% in the Democratic Republic of the Congo to 78.1% in Israel; three surveys reported rates below 60%.
- Stratified per country, 29/47 (62%) general-public surveys reported acceptance ≥70%; the review analyzed 60 surveys total: 47 among the general public, 8 among healthcare workers, 3 among parents/guardians, and 2 among university students.
- Male sex was associated with significantly higher COVID-19 vaccine acceptance in 15 countries/studies, while age was a significant factor in 11 studies/countries.
Methods
- PRISMA-guided systematic search of PubMed/Medline as of 25 December 2020 for English peer-reviewed survey studies evaluating COVID-19 vaccine acceptance/hesitancy; 178 records were identified, 30 articles were included, and one additional Jordan/Kuwait article was added, yielding 31 studies from 33 countries.
- Data extracted included survey date, country/countries, target population, total respondents, and COVID-19 vaccine acceptance rate, defined as respondents answering agree/somewhat/completely agree/leaning towards yes/definitely yes.
- Findings were synthesized descriptively, with acceptance rates stratified by country and target population.
Limitations
- The paper states that reliance on PubMed alone may have missed relevant studies, citing the example of Head et al.; included studies were cross-sectional with different sampling strategies, so results are snapshots and cannot predict future changes in acceptance.
- The paper states that studies used different approaches to express willingness to accept COVID-19 vaccines (e.g., binary yes/no vs. Likert-type scales), which should be considered when comparing acceptance rates.
- Evident from the text: the review added one recently published Jordan/Kuwait article outside the systematic search, and it reports a descriptive synthesis rather than a formal meta-analysis or quality appraisal.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
12 Not checked yet · 10 Own result · 6 No basis given · 4 Own method · 4 Own interpretation
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In the majority of survey studies among the general public stratified per country (29/47, 62%), the acceptance of COVID-19 vaccination showed a level of ≥70%.”
§ COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Survey studies on COVID-19 vaccine acceptance rates were found from 33 different countries.”
- Also stated in: § 3.1. Characteristics of the Papers Included in This Review · plain
“These studies comprised surveys on COVID-19 vaccine acceptance from a total of 33 different countries.”
§ COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 3.1. Characteristics of the Papers Included in This Review · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Low rates of COVID-19 vaccine acceptance were reported in the Middle East, Russia, Africa and several European countries.”
- Also stated in: § 5. Conclusions · plain
“Low COVID-19 vaccine acceptance rates were more pronounced in the Middle East, Eastern Europe and Russia.”
§ COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 5. Conclusions · plain
In the paper
“Results from 31 peer-reviewed published studies met the inclusion criteria and formed the basis for the final COVID-19 vaccine acceptance estimates.”
- Also stated in: § 3.1. Characteristics of the Papers Included in This Review · plain
“A total of 30 published papers were analysed in this review, with an additional recently published article that focused on COVID-19 vaccine acceptance in Jordan and Kuwait to yield a total of 31 studies.”
§ COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates > Abstract
What the sources say
- Not checked yetcites [45] Sallam, M., Dababseh, D., Eid, H., Al-Mahzoum, K., Al-Haidar, A., Taim, D., Yaseen, A., Ababneh, N.A., Bakri, F.G., and Mahafzah, A. (2021). High rates of COVID-19 vaccine hesitancy and its association with conspiracy beliefs: A study in Jordan and Kuwait among other Arab countries. Vaccines, 9. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 3.1. Characteristics of the Papers Included in This Review · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Among adults representing the general public, the highest COVID-19 vaccine acceptance rates were found in Ecuador (97.0%), Malaysia (94.3%), Indonesia (93.3%) and China (91.3%).”
- Also stated in: § 3.2. Rates of COVID-19 Vaccine Acceptance · plain
“Classified per study, the highest vaccine acceptance rates (>90%) among the general public were found in four studies from Ecuador (97.0%), Malaysia (94.3%), Indonesia (93.3%) and China (91.3%).”
§ COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 3.2. Rates of COVID-19 Vaccine Acceptance · plain
In the paper
“Only two surveys among the general public in African countries reported an acceptance rate of 81.6% in South Africa and 65.2% in Nigeria [46].”
§ COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates > 4. Discussion
What the sources say
- Not checked yetcites [46] Lazarus, J.V., Ratzan, S.C., Palayew, A., Gostin, L.O., Larson, H.J., Rabin, K., Kimball, S., and El-Mohandes, A. (2020). A global survey of potential acceptance of a COVID-19 vaccine. Nat. Med. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Male sex was associated with significantly higher rates of COVID-19 vaccine in 15 countries/studies, while the age was a significant factor in 11 studies/countries.”
§ COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates > 3. Results > 3.2. Rates of COVID-19 Vaccine Acceptance
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In this review, a large variability in COVID-19 vaccine acceptance rates was found.”
- Also stated in: § 5. Conclusions · plain
“Large variability in COVID-19 vaccine acceptance rates was reported in different countries and regions of the world.”
§ COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates > 4. Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 5. Conclusions · plain
In the paper
“Early knowledge, attitudes and practices survey study towards COVID-19, from North-Central Nigeria, reported an acceptance rate of barely 29.0%, which highlights the need for more studies for an accurate depiction of COVID-19 vaccine hesitancy in Africa due to possible large regional and sub-regional variations [102].”
§ COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates > 4. Discussion
What the sources say
- Not checked yetcites [102] Reuben, R.C., Danladi, M.M.A., Saleh, D.A., and Ejembi, P.E. (2020). Knowledge, Attitudes and Practices Towards COVID-19: An Epidemiological Survey in North-Central Nigeria. J. Community Health. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Male sex was associated with significantly higher rates of COVID-19 vaccine in 15 countries/studies, while the age was a significant factor in 11 studies/countries.”
§ COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates > 3. Results > 3.2. Rates of COVID-19 Vaccine Acceptance
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 11
- Probably not a substantial claim. 4
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Only eight surveys among healthcare workers (doctors and nurses) were found, with vaccine acceptance rates ranging from 27.7% in the Democratic Republic of the Congo to 78.1% in Israel.”
- Also stated in: § 3.2. Rates of COVID-19 Vaccine Acceptance · plain
“For the eight studies conducted on healthcare workers, three surveys reported vaccine acceptance rates below 60%, with the highest rate being among doctors in Israel (78.1%) and the lowest vaccine acceptance rate (27.7%) reported among healthcare workers in the Democratic Republic of the Congo (DRC).”
§ COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Also stated in: § 3.2. Rates of COVID-19 Vaccine Acceptance · plain
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, the lowest COVID-19 vaccine acceptance rates were found in Kuwait (23.6%), Jordan (28.4%), Italy (53.7), Russia (54.9%), Poland (56.3%), US (56.9%), and France (58.9%).”
- Also stated in: § 3.2. Rates of COVID-19 Vaccine Acceptance · plain
“On the contrary, the lowest vaccine acceptance rates (<60%) among the general public were found in seven studies to be from Kuwait (23.6%), Jordan (28.4%), Italy (53.7), Russia (54.9%), Poland (56.3%), US (56.9%), and France (58.9%).”
§ COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates > Abstract
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Also stated in: § 3.2. Rates of COVID-19 Vaccine Acceptance · plain
In the paper
“However, the highest vaccine acceptance rate was reported in Israel (75.0%); however, this rate was much lower among nurses surveyed in the same study (61.1%) [53].”
§ COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates > 4. Discussion
What the sources say
- Not checked yetcites [53] Dror, 2020, Vaccine hesitancy: The next challenge in the fight against COVID-19, Eur. J. Epidemiol. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In France, the vaccine acceptance rate ranged from 62.0% to 77.1% in March/April and was 58.9% in June.”
§ COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates > 3. Results > 3.3. Changes in COVID-19 Vaccine Acceptance over Time in Countries with Multiple Survey Studies
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In the UK, the vaccine acceptance rate was 79.0% in April, 83.0% in May, 71.5% in June, 64.0% in July and 71.7% in September/October.”
§ COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates > 3. Results > 3.3. Changes in COVID-19 Vaccine Acceptance over Time in Countries with Multiple Survey Studies
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
None of the sources cited for this claim have been checked yet.
In the paper
“The acceptance rate was the lowest in Kuwait (23.6%), followed by Jordan (28.4%), Saudi Arabia (64.7%) and Turkey (66.0%) [45,62,75].”
§ COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates > 4. Discussion
What the sources say
- Not checked yetcites [45] Sallam, M., Dababseh, D., Eid, H., Al-Mahzoum, K., Al-Haidar, A., Taim, D., Yaseen, A., Ababneh, N.A., Bakri, F.G., and Mahafzah, A. (2021). High rates of COVID-19 vaccine hesitancy and its association with conspiracy beliefs: A study in Jordan and Kuwait among other Arab countries. Vaccines, 9. source
- Not checked yetcites [62] Salali, G.D., and Uysal, M.S. (2020). COVID-19 vaccine hesitancy is associated with beliefs on the origin of the novel coronavirus in the UK and Turkey. Psychol. Med., 1–3. source
- Not checked yetcites [75] Padhi, 2020, Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey, J. Multidiscip. Healthc. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“For the vaccine acceptance rates in the US, it was 56.9% in April, and ranged from 67.0% to 75.0% in May, and reached 75.4% in June.”
§ COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates > 3. Results > 3.3. Changes in COVID-19 Vaccine Acceptance over Time in Countries with Multiple Survey Studies
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In Italy, the vaccine acceptance rate was 77.3% in April, 70.8% in June and it reached 53.7% in September.”
§ COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates > 3. Results > 3.3. Changes in COVID-19 Vaccine Acceptance over Time in Countries with Multiple Survey Studies
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“This review was conducted following the PRISMA guidelines [44].”
§ COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates > 2. Materials and Methods
What the sources say
- Not checked yetcites [44] Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., and Group, P. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med., 6. source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The inclusion criteria were: (1) peer-reviewed published articles indexed in PubMed; (2) survey studies among the general population, health-care workers, students, or parents/guardians); (3) the major aim of the study was to evaluate COVID-19 vaccine acceptance/hesitancy; and (4) publication language was English.”
§ COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates > 2. Materials and Methods
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“High acceptance rates in East and South East Asia would help to achieve proper control of the pandemic.”
§ COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates > 5. Conclusions
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“A sizable number of studies reported COVID-19 acceptance rates below 60%, which would pose a serious problem for efforts to control the current COVID-19 pandemic.”
§ COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates > 5. Conclusions
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“In addition, the research studies included in this review represented cross-sectional studies, which can be seen as snapshots of vaccine hesitancy status in each country/region, with different sampling strategies, which may partly explain the differences in vaccine acceptance rates reported in various studies from a single country.”
§ COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates > 4. Discussion
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“The relatively high rates of COVID-19 vaccine acceptance might be related to stronger confidence in vaccine safety and effectiveness, as reported previously in Asia [27].”
§ COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates > 4. Discussion
What the sources say
- Not checked yetcites [27] Larson, 2016, The State of Vaccine Confidence 2016: Global Insights Through a 67-Country Survey, EBioMedicine source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“current acceptance rates of 56–75%245 may be insufficient to reach at least 80–90% coverage246, the threshold thought to be necessary for herd immunity against SARS-CoV-2.”
From mRNA vaccines for infectious diseases: principles, delivery and clinical translation (2021) · cites this paper as [245]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates > 3. Results > 3.2. Rates of COVID-19 Vaccine Acceptance
“For the two studies among University students, the vaccine acceptance rate was 57.3% in Malta (excluding university staff), and 86.1% in Italy.”
§ COVID-19 Vaccine Hesitancy Worldwide: A Concise Systematic Review of Vaccine Acceptance Rates > 4. Discussion
“In addition, low rates of COVID-19 vaccine acceptance were reported among students and healthcare workers in Malta—44.2% and 52.0%, respectively [73,74].”
Citations
Cites
3 retracted
Grech, V., Gauci, C., & Agius, S. (2020) · Early Human Development · doi:10.1016/j.earlhumdev.2020.105213 · Cited by 117
RetractedGrech, V., & Gauci, C. (2020) · Early Human Development · doi:10.1016/j.earlhumdev.2020.105258 · Cited by 49
RetractedGrech, V., Bonnici, J. J., & Zammit, D. (2020) · Early Human Development · doi:10.1016/j.earlhumdev.2020.105259 · Cited by 32
RetractedPreferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,762
The socio-economic implications of the coronavirus pandemic (COVID-19): a review
Nicola, M., Alsafi, Z., Sohrabi, C., Kerwan, A., Al-Jabir, A., Iosifidis, C., Agha, M., & Agha, R. (2020) · International Journal of Surgery · doi:10.1016/j.ijsu.2020.04.018 · Cited by 6,351
Vaccine hesitancy: Definition, scope and determinants
MacDonald, N. E. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.04.036 · Cited by 5,573
Korber, B., Fischer, W. M., Gnanakaran, S., Yoon, H., Theiler, J., Abfalterer, W., Hengartner, N., Giorgi, E. E., Bhattacharya, T., Foley, B., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.043 · Cited by 4,281
A global survey of potential acceptance of a COVID-19 vaccine
Lazarus, J. V., Ratzan, S. C., Palayew, A., Gostin, L. O., Larson, H. J., Rabin, K., Kimball, S., & El-Mohandes, A. (2021) · Nature Medicine · doi:10.1038/s41591-020-1124-9 · Cited by 2,904
Nguyen, L. H., Drew, D. A., Graham, M. S., Joshi, A. D., Guo, C., Ma, W., Mehta, R. S., Warner, E. T., Sikavi, D. R., Lo, C., et al. (2020) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30164-x · Cited by 2,454
Viner, R. M., Russell, S. J., Croker, H., Packer, J., Ward, J., Stansfield, C., Mytton, O., Bonell, C., & Booy, R. (2020) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(20)30095-x · Cited by 2,213
Prem, K., Liu, Y., Russell, T., Kucharski, A. J., Eggo, R. M., Davies, N. G. M., Flasche, S., Clifford, S., Pearson, C. A. B., Munday, J. D., et al. (2020) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30073-6 · Cited by 2,179
Vaccine hesitancy: the next challenge in the fight against COVID-19
Dror, A. A., Eisenbach, N., Taiber, S., Morozov, N. G., Mizrachi, M., Zigron, A., Srouji, S., & Sela, E. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00671-y · Cited by 1,717
Developing Covid-19 Vaccines at Pandemic Speed
Lurie, N., Saville, M., Hatchett, R., & Halton, J. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2005630 · Cited by 1,557
Determinants of COVID-19 vaccine acceptance in the US
Malik, A. A., McFadden, S. M., Elharake, J. A., & Omer, S. B. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100495 · Cited by 1,543
Rational use of face masks in the COVID-19 pandemic
Feng, S., Shen, C., Xia, N., Song, W., Fan, M., & Cowling, B. J. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30134-x · Cited by 1,443
Murphy, J., Vallières, F., Bentall, R. P., Shevlin, M. E., McBride, O., Hartman, T. K., McKay, R., Bennett, K. M., Mason, L., Miller, J. G., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20226-9 · Cited by 1,331
The State of Vaccine Confidence 2016: Global Insights Through a 67-Country Survey
Larson, H. J., de Figueiredo, A., Xiahong, Z., Schulz, W. S., Verger, P., Johnston, I. G., Cook, A. R., & Jones, N. S. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.08.042 · Cited by 1,264
The experiences of health-care providers during the COVID-19 crisis in China: a qualitative study
Liu, Q., Luo, D., Haase, J., Guo, Q.-H., Wang, X.-Q., Liu, S., Xia, L., Liu, Z., Yang, J., & Yang, B. X. (2020) · Lancet Global Health · doi:10.1016/s2214-109x(20)30204-7 · Cited by 1,251
Attitudes Toward a Potential SARS-CoV-2 Vaccine
Fisher, K. A., Bloomstone, S. J., WALDER, J. R., Crawford, S. L., Fouayzi, H., & Mazor, K. M. (2020) · Annals of Internal Medicine · doi:10.7326/m20-3569 · Cited by 1,176
de Figueiredo, A., Simas, C., Karafillakis, E., Paterson, P., & Larson, H. J. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31558-0 · Cited by 1,143
Reiter, P. L., Pennell, M. L., & Katz, M. L. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.08.043 · Cited by 1,102
Attitudes to vaccination: A critical review
Yaqub, O., Castle-Clarke, S., Sevdalis, N., & Chataway, J. (2014) · Social Science & Medicine · doi:10.1016/j.socscimed.2014.04.018 · Cited by 1,089
Vaccine hesitancy, vaccine refusal and the anti-vaccine movement: influence, impact and implications
Dubé, È., Vivion, M., & MacDonald, N. E. (2014) · Expert Review of Vaccines · doi:10.1586/14760584.2015.964212 · Cited by 1,042
Paul, E., Steptoe, A., & Fancourt, D. E. (2020) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2020.100012 · Cited by 1,014
Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19
Neumann‐Böhme, S., Varghese, N. E., Sabat, I., Barros, P. P., Brouwer, W. B. F., van Exel, J. N. A., Schreyögg, J., & Stargardt, T. (2020) · The European Journal of Health Economics · doi:10.1007/s10198-020-01208-6 · Cited by 1,012
Acceptance of COVID-19 Vaccination during the COVID-19 Pandemic in China
Wang, J., Jing, R., Lai, X., Zhang, H., Lyu, Y., Knoll, M. D., & Fang, H. (2020) · Vaccines · doi:10.3390/vaccines8030482 · Cited by 982
Addressing the vaccine confidence gap
Larson, H. J., Cooper, L. Z., Eskola, J., Katz, S. L., & Ratzan, S. C. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60678-8 · Cited by 910
Physical and mental health impacts of COVID-19 on healthcare workers: A scoping review
Shaukat, N., Ali, D. M., & Razzak, J. (2020) · International Journal of Emergency Medicine · doi:10.1186/s12245-020-00299-5 · Cited by 879
Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review
Lin, C., Tu, P., & Beitsch, L. M. (2020) · Vaccines · doi:10.3390/vaccines9010016 · Cited by 859
The psychological roots of anti-vaccination attitudes: A 24-nation investigation.
Hornsey, M. J., Harris, E. A., & Fielding, K. S. (2018) · Health Psychology · doi:10.1037/hea0000586 · Cited by 852
Wong, L. P., Alias, H., Wong, P.-F., Lee, H. Y., & AbuBakar, S. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1790279 · Cited by 814
Freeman, D. H., Loe, B. S., Chadwick, A., Vaccari, C., Waite, F., Rosebrock, L. E., Jenner, L., Petit, A., Lewandowsky, S., Vanderslott, S., et al. (2020) · Psychological Medicine · doi:10.1017/s0033291720005188 · Cited by 802
Rapid COVID-19 vaccine development
Graham, B. S. (2020) · Science · doi:10.1126/science.abb8923 · Cited by 771
Determinants of COVID-19 Vaccine Acceptance in Saudi Arabia: A Web-Based National Survey
Padhi, B. K., & Al-Mohaithef, M. (2020) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s276771 · Cited by 767
Impact of anti-vaccine movements on pertussis control: the untold story
Gangarosa, E., Gałazka, A., Wolfe, C., Phillips, L., Miller, E., Chen, R., & Gangarosa, R. E. (1998) · The Lancet · doi:10.1016/s0140-6736(97)04334-1 · Cited by 749
Sherman, S. M., Smith, L., Sim, J., Amlôt, R., Cutts, M., Dasch, H. K., Rubin, G. J., & Sevdalis, N. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1846397 · Cited by 748
Acceptance of a COVID-19 Vaccine in Southeast Asia: A Cross-Sectional Study in Indonesia
Harapan, H., Wagner, A. L., Yufika, A., Winardi, W., Anwar, S., Gan, A. K., Setiawan, A. M., Rajamoorthy, Y., Sofyan, H., & Mudatsir, M. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00381 · Cited by 708
Kwok, K. O., Li, K., Wei, W. I., Tang, A., Wong, S. Y. S., & Lee, S. S. (2020) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2020.103854 · Cited by 690
Understanding COVID-19 vaccine demand and hesitancy: A nationwide online survey in China
Lin, Y., Hu, Z., Zhao, Q., Alias, H., Danaee, M., & Wong, L. P. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008961 · Cited by 688
Association Between Vaccine Refusal and Vaccine-Preventable Diseases in the United States
Phadke, V. K., Bednarczyk, R. A., Salmon, D. A., & Omer, S. B. (2016) · JAMA · doi:10.1001/jama.2016.1353 · Cited by 677
Sallam, M., Dababseh, D., Eid, H., Al-Mahzoum, K., Al-Haidar, A., Taim, D., Yaseen, A., Ababneh, N. A., Bakri, F. G., & Mahafzah, A. (2021) · Vaccines · doi:10.3390/vaccines9010042 · Cited by 675
Self-citationDetoc, M., Bruel, S., Frappé, P., Tardy, B., Botelho-Nevers, É., & Gagneux‐Brunon, A. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.09.041 · Cited by 661
Britton, T., Ball, F., & Trapman, P. (2020) · Science · doi:10.1126/science.abc6810 · Cited by 645
Bell, S., Clarke, R. M., Mounier‐Jack, S., Walker, J. L., & Paterson, P. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.10.027 · Cited by 576
A Review of the Progress and Challenges of Developing a Vaccine for COVID-19
Sharma, O., Sultan, A. A., Ding, H., & Triggle, C. R. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.585354 · Cited by 570
Gagneux‐Brunon, A., Detoc, M., Bruel, S., Tardy, B., Rozaire, O., Frappé, P., & Botelho-Nevers, É. (2020) · Journal of Hospital Infection · doi:10.1016/j.jhin.2020.11.020 · Cited by 560
Lane, S., MacDonald, N. E., Marti, M., & Dumolard, L. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.03.063 · Cited by 530
Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination
Anderson, R. M., Vegvari, C., Truscott, J., & Collyer, B. S. (2020) · The Lancet · doi:10.1016/s0140-6736(20)32318-7 · Cited by 529
Reuben, R. C., Danladi, M. M. A., Saleh, D. A., & Ejembi, P. E. (2021) · Journal of Community Health · doi:10.1007/s10900-020-00881-1 · Cited by 522
Influences on Attitudes Regarding Potential COVID-19 Vaccination in the United States
Pogue, K., Jensen, J. L., Stancil, C. K., Ferguson, D. G., Hughes, S., Mello, E. J., Burgess, R., Berges, B. K., Quaye, A., & Poole, B. D. (2020) · Vaccines · doi:10.3390/vaccines8040582 · Cited by 515
Salmon, D. A., Dudley, M. Z., Glanz, J. M., & Omer, S. B. (2015) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2015.06.009 · Cited by 493
Fearing the disease or the vaccine: The case of COVID-19
Karlsson, L. C., Soveri, A., Lewandowsky, S., Karlsson, L., Karlsson, H., Nolvi, S., Karukivi, M., Lindfelt, M., & Antfolk, J. (2020) · Personality and Individual Differences · doi:10.1016/j.paid.2020.110590 · Cited by 491
Palamenghi, L., Barello, S., Boccia, S., & Graffigna, G. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00675-8 · Cited by 483
Hamadani, J. D., Hasan, M. I., Baldi, A., Hossain, S. J., Shiraji, S., Bhuiyan, M. S. A., Mehrin, S. F., Fisher, J., Tofail, F., Tipu, S. M. M. U., et al. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30366-1 · Cited by 479
Vaccine confidence in the time of COVID-19
Harrison, E. A., & Wu, J. W. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00634-3 · Cited by 477
Nzaji, M. K., Ngombe, L. K., Mwamba, G. N., Ndala, D. B. B., Miema, J. M., Lungoyo, C. L., Bertin-Lora, M., Bene, A. C. M., & Musenga, E. M. (2020) · Pragmatic and Observational Research · doi:10.2147/por.s271096 · Cited by 427
‘Vaccine hesitancy’ among university students in Italy during the COVID-19 pandemic
Barello, S., Nania, T., Dellafiore, F., Graffigna, G., & Caruso, R. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00670-z · Cited by 422
Ward, J. K., Alleaume, C., Peretti‐Watel, P., Peretti‐Watel, P., Seror, V., Cortaredona, S., Launay, O., Raude, J., Verger, P., Beck, F., et al. (2020) · Social Science & Medicine · doi:10.1016/j.socscimed.2020.113414 · Cited by 418
Salali, G. D., & Uysal, M. S. (2022) · Psychological Medicine · doi:10.1017/s0033291720004067 · Cited by 415
Wang, K., Wong, E. L., Ho, K., Cheung, A. W. L., Chan, E. Y. Y., Yeoh, E., & Wong, S. Y. S. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.09.021 · Cited by 388
Making Sense of Mutation: What D614G Means for the COVID-19 Pandemic Remains Unclear
Grubaugh, N. D., Hanage, W. P., & Rasmussen, A. L. (2020) · Cell · doi:10.1016/j.cell.2020.06.040 · Cited by 353
The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation
Wang, J., Peng, Y., Xu, H., Cui, Z., & Williams, R. O. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-020-01744-7 · Cited by 335
Towards effective COVID‑19 vaccines: Updates, perspectives and challenges (Review)
Călina, D. C., Docea, A. O., Petrakis, D., Egorov, A. M., Ishmukhametov, A. A., Gabibov, A., Штильман, М. И., Kostoff, R. N., Carvalho, F. D., Vinceti, M., et al. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4596 · Cited by 319
Karafillakis, E., & Larson, H. J. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.07.061 · Cited by 317
Ten considerations for effectively managing the COVID-19 transition
Habersaat, K. B., Betsch, C., Danchin, M. H., Sunstein, C. R., BOHM, R. M., Falk, A., Brewer, N. T., Omer, S. B., Scherzer, M., Sah, S., et al. (2020) · Nature Human Behaviour · doi:10.1038/s41562-020-0906-x · Cited by 315
Covid-19: New coronavirus variant is identified in UK
Wise, J. (2020) · British medical journal · doi:10.1136/bmj.m4857 · Cited by 307
Willingness to vaccinate against COVID-19 in Australia
Dodd, R. H., Cvejic, E., Bonner, C., Pickles, K. M., McCaffery, K. J., Ayre, J., Batcup, C., Copp, T., Cornell, S., Dakin, T., et al. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30559-4 · Cited by 282
Taylor, S. J., Landry, C. A., Paluszek, M. M., Groenewoud, R., Rachor, G. S., & Asmundson, G. J. G. (2020) · Frontiers in Psychology · doi:10.3389/fpsyg.2020.575950 · Cited by 282
Vaccine hesitancy: understanding better to address better
Kumar, D., Chandra, R., Mathur, M., Samdariya, S., & Kapoor, N. (2016) · Israel Journal of Health Policy Research · doi:10.1186/s13584-016-0062-y · Cited by 270
Intention to vaccinate against COVID-19 in Australia
Rhodes, A., Hoq, M., Measey, M., & Danchin, M. H. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30724-6 · Cited by 260
Billah, M. A., Miah, M. M., & Khan, M. N. (2020) · PLOS ONE · doi:10.1371/journal.pone.0242128 · Cited by 260
Sallam, M., Dababseh, D., Yaseen, A. I. B., Al-Haidar, A., Ababneh, N. A., Bakri, F. G., & Mahafzah, A. M. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17144915 · Cited by 259
Self-citationOlson, O., Berry, C. N., & Kumar, N. (2020) · Vaccines · doi:10.3390/vaccines8040590 · Cited by 253
The rise (and fall?) of parental vaccine hesitancy
Gowda, C., & Dempsey, A. F. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.25085 · Cited by 252
Browne, M., Thomson, P., Rockloff, M., & Pennycook, G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132562 · Cited by 249
Olagoke, A. A., Olagoke, O. O., & Hughes, A. M. (2020) · Journal of Religion and Health · doi:10.1007/s10943-020-01090-9 · Cited by 244
Zhang, K. C., Fang, Y., Cao, H., Chen, H., Hu, T., Chen, Y., Zhou, X., & Wang, Z. J. (2020) · JMIR Pediatrics and Parenting · doi:10.2196/24827 · Cited by 239
Unraveling R0: Considerations for Public Health Applications
Ridenhour, B. J., Kowalik, J. M., & Shay, D. K. (2013) · American Journal of Public Health · doi:10.2105/ajph.2013.301704 · Cited by 213
Head, K. J., Kasting, M. L., Sturm, L. A., Hartsock, J. A., & Zimet, G. D. (2020) · Science Communication · doi:10.1177/1075547020960463 · Cited by 205
Sallam, M., Dababseh, D., Yaseen, A. I. B., Al-Haidar, A., Taim, D., Eid, H., Ababneh, N. A., Bakri, F. G., & Mahafzah, A. M. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243264 · Cited by 183
Self-citationComparisons of Vaccine Hesitancy across Five Low- and Middle-Income Countries
Wagner, A. L., Masters, N. B., Domek, G. J., Mathew, J. L., Sun, X., Asturias, E. J., Ren, J., Huang, Z., Contreras-Roldan, I. L., Gebremeskel, B., et al. (2019) · Vaccines · doi:10.3390/vaccines7040155 · Cited by 180
Anti-Vaccine Decision-Making and Measles Resurgence in the United States
Benecke, O., & DeYoung, S. E. (2019) · Global Pediatric Health · doi:10.1177/2333794x19862949 · Cited by 168
Addressing parents’ vaccine concerns: a randomized trial of a social media intervention
Daley, M. F., Narwaney, K. J., Shoup, J. A., Wagner, N. M., & Glanz, J. M. (2018) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2018.04.010 · Cited by 164
Religious exception for vaccination or religious excuses for avoiding vaccination
Pelčić, G., Karačić, S., Микиртичан, Г. Л., Kubar, O. I., Leavitt, F. J., Tai, M. C.-T., Morishita, N., Vuletić, S. A., & Tomašević, L. (2016) · Croatian Medical Journal · doi:10.3325/cmj.2016.57.516 · Cited by 162
Vaccine hesitancy: a generation at risk
Health, T. L. C. A. (2019) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(19)30092-6 · Cited by 160
The demand for a COVID-19 vaccine in Ecuador
Sarasty, O., Carpio, C. E., Hudson, D., Guerrero‐Ochoa, P., & Borja, I. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.11.013 · Cited by 149
Hesitant or not? A global survey of potential acceptance of a COVID-19 vaccine
Lazarus, J. V., Ratzan, S., Palayew, A., Gostin, L. O., Larson, H. J., Rabin, K., Kimball, S., & El-Mohandes, A. (2020) · doi:10.1101/2020.08.23.20180307 · Cited by 128
Wong, L. P., Wong, P., & AbuBakar, S. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1706935 · Cited by 109
Combating Vaccine Hesitancy: Teaching the Next Generation to Navigate Through the Post Truth Era
Arede, M., Araya, M. B., Bouchard, É., Gill, G. S., Plajer, V., Shehraj, A., & Shuaib, Y. A. (2019) · Frontiers in Public Health · doi:10.3389/fpubh.2018.00381 · Cited by 105
COVID-19 Vaccine To Vaccination: Why Leaders Must Invest In Delivery Strategies Now
Weintraub, R., Subramanian, L., Karlage, A., Ahmad, I., & Rosenberg, J. (2020) · Health Affairs · doi:10.1377/hlthaff.2020.01523 · Cited by 103
Phylogenetic and phylodynamic analyses of SARS-CoV-2
Nie, Q. H., Li, X., Chen, W., Liu, D., Chen, Y., Li, H., Li, D., Tian, M., Tan, W. C. C., & Zai, J. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198098 · Cited by 97
Conspiracy and Misperception Belief in the Middle East and North Africa
Nyhan, B. J., & Zeitzoff, T. (2018) · The Journal of Politics · doi:10.1086/698663 · Cited by 86
Vecchia, C. L., Negri, E., Alicandro, G., & Scarpino, V. (2020) · La Medicina del Lavoro · doi:10.23749/mdl.v111i6.10813 · Cited by 84
Influences on Attitudes regarding Potential COVID-19 Vaccination in the United States
Pogue, K., Jensen, J., Stancil, C., Ferguson, D., Hughes, S., Mello, E., Burgess, R., Berges, B., Quaye, A., & Poole, B. D. (2020) · doi:10.20944/preprints202009.0338.v1 · Cited by 78
Unraveling R0: Considerations for Public Health Applications
Ridenhour, B. J., Kowalik, J. M., & Shay, D. K. (2018) · American Journal of Public Health · doi:10.2105/ajph.2013.301704r · Cited by 71
Vaccines against Coronaviruses: The State of the Art
Conte, C., Sogni, F., Affanni, P., Veronesi, L., Argentiero, A., & Esposito, S. (2020) · Vaccines · doi:10.3390/vaccines8020309 · Cited by 60
Sherman, S. M., Smith, L. E., Sim, J., Amlôt, R., Cutts, M., Dasch, H., Rubin, G. J., & Sevdalis, N. (2020) · doi:10.1101/2020.08.13.20174045 · Cited by 49
Association of cognitive biases with human papillomavirus vaccine hesitancy: a cross-sectional study
Pomares, T. D., Buttenheim, A. M., Amin, A. B., Joyce, C. M., Porter, R. M., Bednarczyk, R. A., & Omer, S. B. (2019) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2019.1698243 · Cited by 44
The re-emergency and persistence of vaccine preventable diseases
Borba, R., Vidal, V. M., & Moreira, L. O. (2015) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765201520140663 · Cited by 35
Sallam, M., Dababseh, D., Yaseen, A., Al-Haidar, A., Ababneh, N. A., Bakri, F. G., & Mahafzah, A. (2020) · doi:10.21203/rs.3.rs-23343/v1 · Cited by 35
Self-citationTemporal increase in D614G mutation of SARS-CoV-2 in the Middle East and North Africa
Sallam, M., Ababneh, N. A., Dababseh, D., Bakri, F. G., & Mahafzah, A. M. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06035 · Cited by 31
Self-citationCOVID vaccination logistics: five steps to take now
Teerawattananon, Y., & Dabak, S. V. (2020) · Nature · doi:10.1038/d41586-020-03134-2 · Cited by 25
Olagoke, A., Olagoke, O., & Hughes, A. M. (2020) · doi:10.21203/rs.3.rs-31214/v1 · Cited by 5
Zhang, K. C., Fang, Y., Cao, H., Chen, H., Hu, T., Chen, Y. Q., Zhou, X., & Wang, Z. (2020) · doi:10.2196/preprints.24827 · Cited by 2
Cited by
Sorted by citations
mRNA vaccines for infectious diseases: principles, delivery and clinical translation
Chaudhary, N., Weissman, D., & Whitehead, K. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00283-5 · Cited by 1,555
Bobrovitz, N., Ware, H., Ma, X., Li, Z., Hosseini, R., Cao, C., Selemon, A., Whelan, M., Premji, Z., Issa, H., et al. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00801-5 · Cited by 614
Sallam, M., Dababseh, D., Eid, H., Al-Mahzoum, K., Al-Haidar, A., Taim, D., Yaseen, A., Ababneh, N. A., Bakri, F. G., & Mahafzah, A. (2021) · Vaccines · doi:10.3390/vaccines9010042 · Cited by 675
Self-citationThe Nature and Extent of COVID-19 Vaccination Hesitancy in Healthcare Workers
Biswas, N., Mustapha, T. A., Khubchandani, J., & Price, J. H. (2021) · Journal of Community Health · doi:10.1007/s10900-021-00984-3 · Cited by 594
Larson, H. J., Gakidou, E. E., & Murray, C. J. L. (2022) · New England Journal of Medicine · doi:10.1056/nejmra2106441 · Cited by 516
Metadata
- Authors
- Sallam, M.
- Affiliations
- University of Jordan (JO)
- Corresponding author
- Sallam, Malik
- ORCID
- Sallam, Malik
- Venue
- Vaccines
- Publisher
- MDPI AG
- Published
- 2021-02-16
- Volume
- 9
- Issue
- 2
- Pages
- 160
- ISSN
- 2076-393X (ISSN-L)
- PMC
- PMC7920465
- OpenAlex
- W3132264034
- Semantic Scholar
- 5fdd594a2c5c5e845a8a3dfaca7f554d2d4ec788
- Cited by
- 2,128
- References
- 101
- Citations by year
- 2026: 82 · 2025: 146 · 2024: 270 · 2023: 505 · 2022: 710 · 2021: 410
- FWCI
- 51.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Vaccines (publishedVersion, cc-by)
- medRxiv (acceptedVersion, cc-by-nc-nd)
- Preprints.org (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- SUNScholar (Stellenbosch University) (submittedVersion)
- Topics
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Social Sciences › Psychology › Clinical Psychology › COVID-19 and Mental Health
- Keywords
- COVID-19 vaccine hesitancy, COVID-19 vaccination, healthcare workers, public trust in vaccination, cross-national comparison
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
